| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000234350.1 |
Ponatinib |
Colon adenocarcinoma |
0.043121648 |
Sensitive |
| ENSG00000234350.1 |
Ponatinib |
Skin cutaneous melanoma |
0.009713763 |
Sensitive |
| ENSG00000234350.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.044305014 |
Resistant |
